{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:35:26Z","timestamp":1787841326913,"version":"build-2784847793"},"reference-count":64,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:p>Xeroderma pigmentosum (XP) is an autosomal recessive genetic disease caused by a defect in the DNA repair system, exhibiting skin cancer on sun exposure. As it is an incurable disease, therapeutic strategies of this disease are critical. This review article takes an attempt to explore the current therapeutic advancements in XP. Different approaches including sun avoidance; surgical removal of cancerous lesions; laser and photodynamic therapy; use of retinoid, 5-fluorouracil, imiquimod, photolyase, and antioxidant; interferon therapy and gene therapy are chosen by doctors and patients to lessen the adverse effects of this disease. Among these options, sun avoidance, use of 5-fluorouracil and imiquimod, and interferon therapy are effective. However, some approaches including laser and photodynamic therapy, and the use of retinoids are effective against skin cancer having severe side effects. Furthermore, surgical removal of cancerous lesions and use of antioxidants are considered to be effective against this disease; however, efficacies of these are not experimentally determined. In addition, some approaches including oral vismodegib, immunotherapy, nicotinamide, acetohexamide, glimepiride-restricted diet are found to be effective to minimize the complications secondary to defects in the nucleotide excision repair (NER) system and also enhance the NER, which are under experimental level yet. Besides these, gene therapy, including the introduction of missing genes and genome edition, may be a promising approach to combat this disease, which is also not well established now. In the near future, these approaches may be effective tools to manage XP.<\/jats:p>","DOI":"10.4103\/ijd.ijd_329_21","type":"journal-article","created":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T03:01:56Z","timestamp":1649818916000},"page":"660-667","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Current Therapeutic Strategies of Xeroderma Pigmentosum"],"prefix":"10.4103","volume":"66","author":[{"given":"Mozammel","family":"Hossain","sequence":"first","affiliation":[{"name":"From the Department of Biochemistry and Molecular Biology, Jahangirnagar University, Dhaka, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraful","family":"Hasan","sequence":"additional","affiliation":[{"name":"From the Department of Biochemistry and Molecular Biology, Jahangirnagar University, Dhaka, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Mahfuz Ali Khan","family":"Shawan","sequence":"additional","affiliation":[{"name":"From the Department of Biochemistry and Molecular Biology, Jahangirnagar University, Dhaka, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subrata","family":"Banik","sequence":"additional","affiliation":[{"name":"From the Department of Biochemistry and Molecular Biology, Jahangirnagar University, Dhaka, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iffat","family":"Jahan","sequence":"additional","affiliation":[{"name":"From the Department of Biochemistry and Molecular Biology, Jahangirnagar University, Dhaka, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250921","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1750-1172-6-70","article-title":"Xeroderma pigmentosum","volume":"6","author":"Lehmann","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"R2-20250921","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.dnarep.2008.01.014","article-title":"Incidence of DNA repair deficiency disorders in western Europe: Xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy","volume":"7","author":"Kleijer","year":"2008","journal-title":"DNA Repair (Amst)"},{"key":"R3-20250921","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.semcdb.2016.01.025","article-title":"Tuberous sclerosis\u2014A model for tumour growth","volume":"52","author":"Dodd","year":"2016","journal-title":"Semin Cell Dev Biol"},{"key":"R4-20250921","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/218652a0","article-title":"Defective repair replication of DNA in xeroderma pigmentosum","volume":"218","author":"Cleaver","year":"1968","journal-title":"Nature"},{"key":"R5-20250921","first-page":"30","article-title":"Photodynamic therapy in the treatment of xeroderma pigmentosum: A case report","author":"Hong","year":"2020","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"R6-20250921","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1600-0781.1996.tb00188.x","article-title":"Enzyme therapy of xeroderma pigmentosum: Safety and efficacy of T4N5 liposome lotion containing a prokaryotic DNA repair enzyme","volume":"12","author":"Yarosh","year":"1996","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"R7-20250921","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1524-4725.1997.tb00084.x","article-title":"The molecular basis of xeroderma pigmentosum","volume":"23","author":"Copeland","year":"1997","journal-title":"Dermatol Surg"},{"key":"R8-20250921","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1011-1344(01)00246-9","article-title":"Effect of xenogenic repair enzymes on photoimmunology and photocarcinogenesis","volume":"65","author":"Stege","year":"2001","journal-title":"J Photochem Photobiol B Biol"},{"key":"R9-20250921","first-page":"4","article-title":"Xeroderma pigmentosum","volume":"13","author":"Norgauer","year":"2003","journal-title":"Eur J Dermatol"},{"key":"R10-20250921","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1073\/pnas.94.1.11","article-title":"Sunlight and skin cancer: Another link revealed","volume":"94","author":"Kraemer","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"R11-20250921","doi-asserted-by":"crossref","first-page":"107S","DOI":"10.1038\/jid.1994.19","article-title":"Relationship between ultraviolet radiation\u2013induced immunosuppression and carcinogenesis","volume":"103","author":"Streilein","year":"1994","journal-title":"J Invest Dermatol"},{"key":"R12-20250921","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrm3822","article-title":"Understanding nucleotide excision repair and its roles in cancer and ageing","volume":"15","author":"Marteijn","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R13-20250921","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1111\/1346-8138.13907","article-title":"Xeroderma pigmentosum clinical practice guidelines revision committee. Xeroderma pigmentosum clinical practice guidelines","volume":"44","author":"Moriwaki","year":"2017","journal-title":"J Dermatol"},{"key":"R14-20250921","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.dnarep.2008.03.016","article-title":"The 8, 5'-cyclopurine-2'-deoxynucleosides: Candidate neurodegenerative DNA lesions in xeroderma pigmentosum, and unique probes of transcription and nucleotide excision repair","volume":"7","author":"Brooks","year":"2008","journal-title":"DNA Repair (Amst)"},{"key":"R15-20250921","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1600-0625.2008.00763.x","article-title":"Strict sun protection results in minimal skin changes in a patient with xeroderma pigmentosum and a novel c.2009delG mutation in XPD (ERCC2)","volume":"18","author":"Emmert","year":"2009","journal-title":"Exp Dermatol"},{"key":"R16-20250921"},{"key":"R18-20250921","doi-asserted-by":"crossref","first-page":"865","DOI":"10.2353\/ajpath.2010.091096","article-title":"In vivo assessment of acute UVB responses in normal and Xeroderma Pigmentosum (XP-C) skin-humanized mouse models","volume":"177","author":"Garc\u00eda","year":"2010","journal-title":"Am J Pathol"},{"key":"R19-20250921","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.jsbmb.2006.12.029","article-title":"Sunlight, skin cancer and vitamin D: What are the conclusions of recent findings that protection against solar ultraviolet (UV) radiation causes 25-hydroxy vitamin D deficiency in solid organ-transplant recipients, xeroderma pigmentosum, and other risk groups?","volume":"103","author":"Reichrath","year":"2007","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R20-20250921","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/0007-1226(87)90156-1","article-title":"Facial resurfacing in xeroderma pigmentosum: Are we spoiling the ship for a ha'p'orth of tar?","volume":"40","author":"Ashall","year":"1987","journal-title":"Br J Plast Surg"},{"key":"R21-20250921","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jcms.2010.03.026","article-title":"Facial resurfacing with split-thickness skin grafts in xeroderma pigmentosum variant","volume":"39","author":"Tayeb","year":"2011","journal-title":"J Cranio-Maxillofacial Surg"},{"key":"R22-20250921","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/0190-9622(95)90348-8","article-title":"The role of dermabrasion and chemical peels in the treatment of patients with xeroderma pigmentosum","volume":"32","author":"Nelson","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"R23-20250921","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/lsm.20012","article-title":"Full face laser resurfacing: Therapy and prophylaxis for actinic keratoses and non-melanoma skin cancer","volume":"34","author":"Iyer","year":"2004","journal-title":"Lasers Surg Med"},{"key":"R24-20250921","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.3390\/nu6031209","article-title":"Vitamin A\/retinol and maintenance of pluripotency of stem cells","volume":"6","author":"Khillan","year":"2014","journal-title":"Nutrients"},{"key":"R25-20250921","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/S0899-9007(00)00436-6","article-title":"Recent advances in the use of vitamin A (retinoids) in the prevention and treatment of cancer","volume":"16","author":"Niles","year":"2000","journal-title":"Nutrition"},{"key":"R26-20250921","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/art.22417","article-title":"Regulation of matrix metalloproteinase gene expression by a retinoid X receptor-specific ligand","volume":"56","author":"Burrage","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R27-20250921","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1056\/NEJM198806233182501","article-title":"Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin","volume":"318","author":"Kraemer","year":"1988","journal-title":"N Engl J Med"},{"key":"R28-20250921","first-page":"498","article-title":"Oral isotretinoin in the treatment and prevention of cutaneous squamous cell carcinoma","volume":"3","author":"Jones","year":"2004","journal-title":"J Drugs Dermato"},{"key":"R29-20250921","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1177\/1203475418814234","article-title":"Comparison of management guidelines for moderate-to-severe plaque psoriasis: A review of phototherapy, systemic therapies, and biologic agents","volume":"23","author":"Ighani","year":"2019","journal-title":"J Cutan Med Surg"},{"key":"R30-20250921","doi-asserted-by":"crossref","first-page":"13182","DOI":"10.1038\/s41598-018-31352-2","article-title":"Polymorphisms of SLCO1B1 rs4149056 and SLC22A1 rs2282143 are associated with responsiveness to acitretin in psoriasis patients","volume":"8","author":"Chen","year":"2018","journal-title":"Sci Rep"},{"key":"R31-20250921","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1067\/mjd.2001.113476","article-title":"Topical 5-fluorouracil to treat multiple or unresectable facial squamous cell carcinomas in Xeroderma Pigmentosum","volume":"44","author":"Hamouda","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"R32-20250921","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/php.12385","article-title":"Development of effective skin cancer treatment and prevention in xeroderma pigmentosum","volume":"91","author":"Lambert","year":"2015","journal-title":"Photochem Photobiol"},{"key":"R33-20250921","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1073\/pnas.72.10.4071","article-title":"Restoration of ultraviolet induced unscheduled DNA synthesis of xeroderma pigmentosum cells by the concomitant treatment with bacteriophage T4 endonuclease V and HVJ (Sendai virus)","volume":"72","author":"Tanaka","year":"1975","journal-title":"Proc Natl Acad Sci USA"},{"key":"R34-20250921","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1525-1470.2008.00727.x","article-title":"Multiple basal cell carcinomas in xeroderma pigmentosum treated with imiquimod 5% cream","volume":"25","author":"Malhotra","year":"2008","journal-title":"Pediatr Dermatol"},{"key":"R35-20250921","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/dth.12217","article-title":"Multiple facial basal cell carcinomas in xeroderma pigmentosum treated with topical imiquimod 5% cream","volume":"28","author":"Yang","year":"2015","journal-title":"Dermatol Ther"},{"key":"R36-20250921","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/978-0-387-09599-8_13","article-title":"Roles of oxidative stress in xeroderma pigmentosum","volume":"637","author":"Hayashi","year":"2008","journal-title":"Adv Exp Med Biol"},{"key":"R37-20250921","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1001\/archderm.1994.01690120027003","article-title":"Clearing of melanoma in situ with intralesional interferon alfa in a patient with xeroderma pigmentosum","volume":"130","author":"Turner","year":"1994","journal-title":"Arch Dermatol"},{"key":"R38-20250921","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.dnarep.2020.102907","article-title":"Molecular analysis directs the prognosis, management and treatment of patients with xeroderma pigmentosum","volume":"93","author":"Lehmann","year":"2020","journal-title":"DNA Repair"},{"key":"R39-20250921","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.semcancer.2019.01.006","article-title":"Cancer immunotherapy with check point inhibitor can cause autoimmune adverse events due to loss of Treg homeostasis","volume":"64","author":"Kumar","year":"2020","journal-title":"Semin Cancer Biol"},{"key":"R40-20250921","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJMoa1506197","article-title":"A phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention","volume":"373","author":"Chen","year":"2015","journal-title":"N Engl J Med"},{"key":"R41-20250921","doi-asserted-by":"crossref","first-page":"E212","DOI":"10.1073\/pnas.1213076110","article-title":"Sirt1 suppresses RNA synthesis after UV irradiation in combined xeroderma pigmentosum group D\/Cockayne syndrome (XP-D\/CS) cells","volume":"110","author":"Velez-Cruz","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"R42-20250921","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.cell.2014.03.026","article-title":"Defective mitophagy in XPA via PARP-1 hyperactivation and NAD(+)\/SIRT1 reduction","volume":"157","author":"Fang","year":"2014","journal-title":"Cell"},{"key":"R43-20250921","doi-asserted-by":"crossref","first-page":"16017","DOI":"10.1038\/npjamd.2016.17","article-title":"It takes two to tango: NAD(+) and sirtuins in aging\/longevity control","volume":"2","author":"Imai","year":"2016","journal-title":"NPJ Aging Mech Dis"},{"key":"R44-20250921","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/bjd.17253","article-title":"Novel therapeutic approaches to xeroderma pigmentosum","volume":"181","author":"Weon","year":"2019","journal-title":"Br J Dermatol"},{"key":"R45-20250921","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.molcel.2017.10.021","article-title":"Repair of UV-induced DNA damage independent of nucleotide excision repair is masked by MUTYH","volume":"68","author":"Mazouzi","year":"2017","journal-title":"Mol Cell"},{"key":"R46-20250921","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nature19329","article-title":"Restricted diet delays accelerated ageing and genomic stress in DNA-repair-deficient mice","volume":"537","author":"Vermeij","year":"2016","journal-title":"Nature"},{"key":"R47-20250921","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1146\/annurev.biochem.74.050304.091637","article-title":"Gene therapy: Twenty-first century medicine","volume":"74","author":"Verma","year":"2005","journal-title":"Annu Rev Biochem"},{"key":"R48-20250921","first-page":"1212","article-title":"Differential behaviors toward ultraviolet A and B radiation of fibroblasts and keratinocytes from normal and DNA-repair-deficient patients","volume":"59","author":"Otto","year":"1999","journal-title":"Cancer Res"},{"key":"R49-20250921","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jmb.2007.04.079","article-title":"Engineered I-CreI derivatives cleaving sequences from the human XPC gene can induce highly efficient gene correction in mammalian cells","volume":"371","author":"Arnould","year":"2007","journal-title":"J Mol Biol"},{"key":"R50-20250921","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nature07343","article-title":"Molecular basis of Xeroderma Pigmentosum group cDNA recognition by engineered meganucleases","volume":"456","author":"Redondo","year":"2008","journal-title":"Nature"},{"key":"R51-20250921","article-title":"The Oxford 2011 Levels of Evidence","author":"Howick","journal-title":"Oxford Centre for Evidence-Based Medicine"},{"key":"R52-20250921","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0738-081X(01)00170-5","article-title":"Laser and photodynamic therapy in the management of cutaneous malignancies","volume":"19","author":"Zeitouni","year":"2001","journal-title":"Clin Dermatol"},{"key":"R53-20250921","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1525-1470.2011.01657.x","article-title":"Photodynamic therapy in a teenage girl with xeroderma pigmentosum type C","volume":"29","author":"Larson","year":"2012","journal-title":"Pediatr Dermatol"},{"key":"R54-20250921","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/01.iop.0000246600.80517.d3","article-title":"Aggravation of eyelid and conjunctival malignancies following photodynamic therapy in DeSanctis-Cacchione syndrome","volume":"22","author":"Procianoy","year":"2006","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"R55-20250921","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0140-6736(00)04214-8","article-title":"Effect of topically applied T4 endonuclease V in liposomes on skin cancer in Xeroderma Pigmentosum: A randomised study","volume":"357","author":"Yarosh","year":"2001","journal-title":"Lancet"},{"key":"R56-20250921","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3109\/09546634.2010.548503","article-title":"Successful treatment and management of large superficial basal cell carcinomas with topical imiquimod 5% cream: A case series and review","volume":"22","author":"Lacarrubba","year":"2011","journal-title":"J Dermatolog Treat"},{"key":"R57-20250921","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1111\/bjd.19323","article-title":"Treatment of multiple facial basal cell carcinomas in a child with xeroderma pigmentosum complementation group C with Mohs micrographic surgery","volume":"184","author":"Greig","year":"2021","journal-title":"Br J Dermatol"},{"key":"R58-20250921","first-page":"136","article-title":"Photoprotection by topical DNA repair enzymes: Molecular correlates of clinical studies","volume":"69","author":"Yarosh","year":"1999","journal-title":"Photochem Photobiol"},{"key":"R59-20250921","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.braindev.2009.09.008","article-title":"Low-dose levodopa is effective for laryngeal dystonia in xeroderma pigmentosum group A","volume":"32","author":"Miyata","year":"2010","journal-title":"Brain Dev"},{"key":"R60-20250921","doi-asserted-by":"crossref","first-page":"e921301","DOI":"10.12659\/AJCR.921301","article-title":"Effect of pegylated interferon and mitomycin C on ocular surface squamous neoplasia in xeroderma pigmentosum: A case series?","volume":"21","author":"Dirar","year":"2020","journal-title":"Am J Case Rep"},{"key":"R61-20250921","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1089\/104303403766682241","article-title":"Genetic correction of DNA repair-deficient\/cancer-prone xeroderma pigmentosum group C keratinocytes","volume":"14","author":"Arnaudeau-B\u00e9gard","year":"2003","journal-title":"Hum Gene Ther"},{"key":"R62-20250921","doi-asserted-by":"crossref","first-page":"17759","DOI":"10.1073\/pnas.0406304101","article-title":"Gene transduction in skin cells: Preventing cancer in Xeroderma Pigmentosum mice","volume":"101","author":"Marchetto","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"R63-20250921","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/mt.2011.233","article-title":"Preclinical corrective gene transfer in xeroderma pigmentosum human skin stem cells","volume":"20","author":"Warrick","year":"2012","journal-title":"Mol Ther"},{"key":"R64-20250921","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.stem.2013.11.002","article-title":"Functional repair of CFTR by CRISPR\/Cas9 in intestinal stem cell organoids of cystic fibrosis patients","volume":"13","author":"Schwank","year":"2013","journal-title":"Cell Stem Cell"},{"key":"R65-20250921","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/21678707.2017.1256770","article-title":"Genetic therapy of xeroderma pigmentosum: Analysis of strategies and translation","volume":"5","author":"Goncalves-Maia","year":"2017","journal-title":"Expert Opin Orphan Drugs"}],"container-title":["Indian Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.ijd_329_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:50:02Z","timestamp":1787838602000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.ijd_329_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":64,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/ijd.ijd_329_21","relation":{},"ISSN":["0019-5154","1998-3611"],"issn-type":[{"value":"0019-5154","type":"print"},{"value":"1998-3611","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"2021-04-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}